Article
The Dearth of Representation in FDA Approved Drug Trials
2024-01-17
Abstract excerpt
The generalizability of data derived from randomized controlled trials is of paramount importance given their utility in the Food & Drug Administration (FDA) drug approval process. An essential part of this process is the inclusion of reliably reported gender, race and ethnicity data in trials that lead to FDA drug approval. Despite previous mandates by the FDA and Clinicaltrials.gov , gender and race-specific dat...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- af639379-5e18-59fa-93b8-24cb7aef9792
- DOI
- 10.1101/2024.01.16.24301376
